(Q68166533)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1611229%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

title

Bronchodilator properties of an inhaled leukotriene D4 antagonist (verlukast--MK-0679) in asthmatic patients (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1611229%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

Bronchodilator properties of an inhaled leukotriene D4 antagonist (verlukast—MK-0679) in asthmatic patients (English)

1 reference

https://api.crossref.org/works/10.1016/0952-0600(92)90029-G

15 October 2022

1 reference

Van den Elshout FM

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1611229%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

J. W. Lammers

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1611229

15 October 2022

P. Van Daele

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1611229

15 October 2022

F. M. Van den Elshout

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1611229

15 October 2022

M. Decramer

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1611229

15 October 2022

A. Buntinx

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1611229

15 October 2022

I. De Lepeleire

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1611229

15 October 2022

B. Friedman

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1611229

15 October 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1611229

15 October 2022

publication date

1 June 1992

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1611229%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

22 September 2019

https://api.elsevier.com/content/article/PII:095206009290029G?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0952-0600(92)90029-G

https://api.elsevier.com/content/article/PII:095206009290029G?httpAccept=text/plain

15 October 2022

1 reference

https://api.crossref.org/works/10.1016/0952-0600(92)90029-G

15 October 2022

published in

Pulmonary pharmacology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1611229%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

volume

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1611229%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1611229%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

page(s)

121-125

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1611229%20AND%20SRC:MED&resulttype=core&format=json

Airway smooth muscle and disease workshop: leukotrienes and related eicosanoids

22 September 2019

cites work

1

1 reference

https://api.crossref.org/works/10.1016/0952-0600(92)90029-G

Leukotrienes and airway responses.

15 October 2022

2

1 reference

https://api.crossref.org/works/10.1016/0952-0600(92)90029-G

Leukotrienes are potent constrictors of human bronchi

15 October 2022

4

1 reference

https://api.crossref.org/works/10.1016/0952-0600(92)90029-G

Leukotrienes C4, D4 and E4 cause widespread and extensive plasma extravasation in the guinea pig.

15 October 2022

6

1 reference

https://api.crossref.org/works/10.1016/0952-0600(92)90029-G

Comparative effects of inhaled leukotriene C4, leukotriene D4, and histamine in normal human subjects

15 October 2022

7

1 reference

https://api.crossref.org/works/10.1016/0952-0600(92)90029-G

Effects of leukotriene D on the airways in asthma

15 October 2022

8

1 reference

https://api.crossref.org/works/10.1016/0952-0600(92)90029-G

The effect of inhaled leukotriene D4 in humans

15 October 2022

9

1 reference

https://api.crossref.org/works/10.1016/0952-0600(92)90029-G

Pharmacology of L-660,711 (MK-571): a novel potent and selective leukotriene D4 receptor antagonist

15 October 2022

10

1 reference

https://api.crossref.org/works/10.1016/0952-0600(92)90029-G

The emergence of potent and selective peptide leukotriene receptor antagonists

15 October 2022

11

1 reference

https://api.crossref.org/works/10.1016/0952-0600(92)90029-G

Lung function improvement in asthma with a cysteinylleukotriene receptor antagonist

15 October 2022

17

1 reference

https://api.crossref.org/works/10.1016/0952-0600(92)90029-G

Inhibition of exercise-induced bronchoconstriction by MK-571, a potent leukotriene D4-receptor antagonist

15 October 2022

18

1 reference

https://api.crossref.org/works/10.1016/0952-0600(92)90029-G

15 October 2022

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1611229%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

1 reference